Dr Ralph & Marian Falk Medical Research Tr Grants
Private foundation · EIN 36-6975534 · IRS 990-PF filings through tax year 2024
- Total grants paid
- $16.1M
- Grants reported
- 75
- Median grant
- $176.2K
- Future commitments
- None reported
Giving by tax year
| Tax year | Grants paid | Amount |
|---|---|---|
| 2024 | 38 | $8.3M |
| 2023 | 37 | $7.8M |
Where Dr Ralph & Marian Falk Medical Research Tr gives
States of grant recipients reported on the foundation's 990-PF filings, by dollars received.
Largest reported grants
The biggest individual grants on file, as reported by the foundation to the IRS.
| Recipient | Location | Purpose | Tax year | Amount |
|---|---|---|---|---|
| UNIVERSITY OF CINCINNATI | CLEVELAND, OH | INHIBITORS TARGETING PEANUT | 2023 | $497K |
| BROWN UNIVERSITY OF PROVIDENCE | PROVIDENCE, RI | ANTI-MALARIA DRUGS TARGETNG | 2023 | $495.1K |
| MEDICAL COLLEGE OF WISCONSIN | MILWAUKEE, WI | NEW DRUGS TO TREAT | 2023 | $377K |
| CASE WESTERN RESERVE UNIVERSITY | CLEVELAND, OH | IMMUNOTHERAPY FOR B CELL | 2024 | $355.8K |
| YALE UNIVERSITY - SCHOOL OF MEDICINE | NEW HAVEN, CT | MAKING CANCER CELLS LOOK | 2024 | $348.3K |
| CASE WESTERN RESERVE UNIVERSITY | CLEVELAND, OH | B CELL CANCER THERAPY USING | 2023 | $343.2K |
| INDIANA UNIVERSITY | BLOOMINGTON, IN | PIM2 MODULATOR-MULTIPLE | 2024 | $340.9K |
| CLEVELAND CLINIC FOUNDATION | CLEVELAND, OH | DEVELOPMENT OF NEW DRUG FOR | 2023 | $336.3K |
| MEDICAL COLLEGE OF WISCONSIN | MILWAUKEE, WI | PAIN THERAPY - SENSORY | 2024 | $334.6K |
| THOMAS JEFFERSON UNIVERSITY | PHILADELPHIA, PA | PROTACS FOR TARGETING BRCA | 2023 | $333.3K |
| THOMAS JEFFERSON UNIVERSITY | PHILADELPHIA, PA | PROTACS FOR TARGETING BRCA | 2024 | $333.3K |
| CLEVELAND CLINIC FOUNDATION | CLEVELAND, OH | DEVELOPMENT OF NEW DRUG FOR | 2024 | $331.9K |
| BOARD REGENTS OF UNIVERSITY OF WISCONSIN | MILWAUKEE, WI | IMPROVE DIAGNOSIS OF BREAST | 2024 | $330.5K |
| MEDICAL COLLEGE OF WISCONSIN | MILWAUKEE, WI | DEVELOPMENT OF SENSORY | 2023 | $318.9K |
| MEDICAL COLLEGE OF WISCONSIN | MILWAUKEE, WI | NEW DRUGS TO TREAT | 2024 | $316K |
| UNIVERSITYOF MINNESOTA | MINNEAPOLIS, MN | T3 THERAPY - HEART FAILURE | 2024 | $308.9K |
| UNIVERSITY OF MINNESOTA | MINNEAPOLIS, MN | OPTIMIZED MECHANISM BASED | 2024 | $284.7K |
| UNIVERSITY OF CHICAGO | CHICAGO, IL | METASTIC LUNG CANCER PHASE | 2024 | $268.7K |
| PURDUE UNIVERSITY | WEST LAFAYETTE, IN | ADVANCING MICRO RNAS AS | 2024 | $257K |
| UNIVERSITYOF MINNESOTA | MINNEAPOLIS, MN | THYROID HORMONE | 2023 | $235.1K |
| NORTHWESTERN UNIVERSITY | EVANSTON, IL | THERAPY FOR CHRONIC KIDNEY | 2024 | $210.4K |
| UNIVERSITY OF IOWA | IOWA CITY, IA | VASCULAR HEALTH TARGETING | 2024 | $208.3K |
| UNIVERSITY OF MINNESOTA | MINNEAPOLIS, MN | SYSTEMIC BACTEREMIA - HOST | 2024 | $203.8K |
| UNIVERSITY OF CHICAGO | CHICAGO, IL | TUMOR ANUEPLOIDY - | 2023 | $200.7K |
| OHIO STATE UNIVERSITY | COLUMBUS, OH | DEVELOP NEW THERAPY FOR | 2023 | $197.9K |
How to apply
This foundation publishes application instructions on its latest 990-PF and does not report restricting giving to preselected organizations. See more foundations that accept applications.
- Contact
- TIMOTHY QUINN - BANK OF AMERICA
- Address
- 110 N WACKER DR FL 7 CHICAGO, IL, 60606
- Phone
- 3128282055
- jbrown@hria.org or ilgrantmaking@bofa.com
- Deadlines
- AUGUST
- Application materials
- Go to hria.org/tmf/falktap/ for applications and procedures
- Restrictions
- MEDICAL RESEARCH TO IMPROVE TREATMENTS OF THE PAST AND EVENTUALLY FIND CURES FOR DISEASES FOR WHICH NO DEFINITE CURE IS KNOWN. MIDWEST RESEARCH LOCATION PREFERENCE.
About this data
Figures are aggregated from Dr Ralph & Marian Falk Medical Research Tr's IRS Form 990-PF electronic filings (2 filings on file, most recent tax year 2024). Totals reflect grants the foundation reported as paid, and can lag the current year because foundations file annually and often on extension. Source: IRS 990-PF e-file archive.